Status:
COMPLETED
OCT in Borderline Coronary Artery Lesions
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Optical Coherence Tomography (OCT)
Percutaneous Coronary Intervention (PCI)
Eligibility:
All Genders
Phase:
NA
Brief Summary
To find out the safety and efficacy of Optical Coherence Tomography (OCT) in the evaluation and treatment of angiographically borderline coronary artery lesions in a Chinese population, and to compare...
Eligibility Criteria
Inclusion
- The inclusion criteria for this study will be only those participants in whom diagnostic coronary angiography revealed borderline coronary artery lesion. These participants will undergo the OCT procedure, or alternatively ECT.
Exclusion
- Exclusion criteria will be those participants with previous cardiogenic shock, stroke, renal dysfunction, and acute or chronic total occlusion coronary lesions.
Key Trial Info
Start Date :
December 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT03229993
Start Date
December 31 2017
End Date
December 31 2019
Last Update
July 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China, 210029